All Q1 FY27 results →
DF

Deepak Fertilis.

Q1 FY27

Deepak Fertilisers & Petrochemicals Corp Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹1,344
Market cap₹17.0K Cr
P/E17.3
Updated16 Oct 2026
Read4 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28. The company is entering the next phase of growth with new capacities (Gopalpur TAN and Dahej nitric acid projects) commissioning in Q2 FY27, expected to contribute from Q3/Q4 FY27 onwards.

From Deepak Fertilis.'s Q1 FY27 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

Moderate growth
  • New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28.
  • Revenue uplift expected from capacity addition is calculable using shared average realizations and known production quantities.
  • Growth will be driven by multiple levers: downstream expansion (DMSL), premiumization in crop nutrition and specialty fertilizers, and increasing specialty industrial chemicals.
  • Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions.
  • Integration benefits from the long-term LNG contract with Equinor and improved ammonia plant utilization will provide cost advantages and support margin stability.

2 more points from Deepak Fertilis.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Deepak Fertilis. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Two major capex projects are in the final stage of commissioning and expected to be operational by end of Q3 FY27:
  • Gopalpur TAN plant (ammonium nitrate)
  • Dahej nitric acid plant
  • These new capacities are expected to start contributing to revenue and EBITDA from Q3/Q4 FY27, with ramp-up possibly reaching around 80% utilization by Q4.
  • The company has capitalized interest costs related to these projects, indicating ongoing investment.
  • The new capacities will bolster integrated supply chain benefits, improve operating leverage, and drive the next growth phase.
  • Management is also evaluating strategic options for the DMSL subsidiary, including IPO or demerger, to unlock value.

2 more points from Deepak Fertilis.'s call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Deepak Fertilis. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The discussion mainly revolves around: - Ammonia plant capacity and utilization (94% in Q1 FY27). - Supply chain and gas contracts with Equinor. - Market outlook regarding fertilizer prices, especially impacts of geopolitical events. - EBITDA, PAT performance and capex updates. - Long-term LNG supply contract benefits.

2 more points from Deepak Fertilis.'s call on order book

Create a free account to keep reading this call

Deepak Fertilis. — Quarterly revenue & net profit

Revenue Net profit
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹3.3K Cr, net profit ₹490 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Alufluoride (Q1 FY27)

    Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr

  • POCL Enterprises (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Devson Catalyst (Q1 FY27)

    FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee

  • Ambani Orgochem (Q1 FY27)

    Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Deepak Fertilis. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Deepak Fertilis. Q1 FY27 results?

New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28. The company is entering the next phase of growth with new capacities (Gopalpur TAN and Dahej nitric acid projects) commissioning in Q2 FY27, expected to contribute from Q3/Q4 FY27 onwards.

What is Deepak Fertilis. share price analysis?

Deepak Fertilis. currently shows a below-average growth signal. The stock trades at a P/E of 17.2 with a market cap of ₹16,968 Cr. Investors should review the full earnings analysis for detailed insights.

Is Deepak Fertilis. planning capital expenditure?

Two major capex projects are in the final stage of commissioning and expected to be operational by end of Q3 FY27: - Gopalpur TAN plant (ammonium nitrate) - Dahej nitric acid plant - These new capacities are expected to start contributing to revenue and EBITDA from Q3/Q4 FY27, with ramp-up possibly reaching around 80% utilization by Q4.

Keep Deepak Fertilis. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.